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Abstract: There is an increased interest in secondary plant metabolites, such as polyphenols and carotenoids, due to
their proposed health benefits. Much attention has focused on their bioavailability, a prerequisite for further physiological
functions. As human studies are time consuming, costly, and restricted by ethical concerns, in vitromodels for investigating
the effects of digestion on these compounds have been developed and employed to predict their release from the food
matrix, bioaccessibility, and assess changes in their profiles prior to absorption. Most typically, models simulate digestion
in the oral cavity, the stomach, the small intestine, and, occasionally, the large intestine. A plethora of models have been
reported, the choice mostly driven by the type of phytochemical studied, whether the purpose is screening or studying
under close physiological conditions, and the availability of the model systems. Unfortunately, the diversity of model
conditions has hampered the ability to compare results across different studies. For example, there is substantial variability
in the time of digestion, concentrations of salts, enzymes, and bile acids used, pH, the inclusion of various digestion
stages; and whether chosen conditions are static (with fixed concentrations of enzymes, bile salts, digesta, and so on)
or dynamic (varying concentrations of these constituents). This review presents an overview of models that have been
employed to study the digestion of both lipophilic and hydrophilic phytochemicals, comparing digestive conditions in
vitro and in vivo and, finally, suggests a set of parameters for static models that resemble physiological conditions.
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Introduction
Phytochemicals are a large and structurally diverse group of
secondary plant metabolites that are nonessential for humans,
that is, their nonconsumption does not cause any specific defi-
ciency symptoms. For the plant, these are also nonessential com-
pounds, but they aid, among other functions, in fending off
herbivores (polyphenols), or stabilizing photosynthetic pigments
(carotenoids). From a chemical point of view, phytochemicals in-
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clude very diverse compounds, from the rather polar polyphenols,
to the rather apolar carotenoids, phytosterols, and terpenes.
There has been increased interest in phytochemicals as their
consumption and body tissue levels have been associated with
several health benefits, especially in relation to the prevention of
chronic diseases such as diabetes, cancer, cardiovascular diseases
(CVD) and neurodegenerative diseases (Krzyzanowska and oth-
ers 2010). This is especially true for their consumption of whole
fruits and vegetables, even though there is controversy about the
compounds and mechanisms responsible for the observed health
benefits. Nevertheless, a number of prospective studies have related
the consumption of phytochemicals, such as of polyphenols and
carotenoids, in form of whole fruits or vegetables with the preven-
tion of chronic diseases (He and others 2007; Carter and others
2010). For example, in various meta-analyses, the consumption
of carotenoids and several types of polyphenols such as flavonoids
were inversely related to the incidence of CVD (Arts and Hollman
2005; Hamer and Chida 2007).
The possible effectiveness, in the human body, of phytochem-
icals is greatly determined by the bioavailability of these bioactive
molecules. The most abundant phytochemicals in our diet are not
necessarily those able to result in the highest tissue concentrations
or those revealing biological effects, owing to considerable differ-
ences in bioavailability (Manach and others 2005). Phytochemical
bioavailability is affected by a large number of factors including
the types of compounds studied, variation in polarity, molecular
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mass, their differing associations with the plant matrix, presence
in crystalline or amorphous state, digestion by gastrointestinal
(GI) enzymes, active compared with passive absorption into
the enterocytes, and many more. Among the most important
factors determining bioavailability, and a prerequisite for intestinal
absorption, is release from the food matrix and solubilization
during digestion, also termed bioaccessibility (Parada and Aguilera
2007). Bioacessibility is, therefore, describing the fraction of a
compound potentially available for further uptake and absorption.
The amount of any phytochemical bioacessible may differ greatly
from its total concentration in the native food matrix. For some
compounds that are poorly released and solubilized, such as
carotenoids (Bohn 2008), or that are degraded prior to reaching
their site of absorption, such as anthocyanins, the portion that
is bioaccessible may be below 10% (Minekus and others 1995;
Bouayed and others 2011). Thus, a thorough understanding
of changes occurring during digestion (such as mechanical
action, enzymatic activities, and altered pH) is crucial for the
understanding of bioaccessibility and estimating bioavailability
and bioactivity, as only bioavailable phytochemicals will exert fully
their potential beneficial effects. Because animal and human stud-
ies are lengthy and costly to conduct, and are limited due to ethical
considerations, in vitro systems have been developed that enable the
prediction of phytochemical changes during oral and GI digestion.
This has allowed the screening of comparatively large numbers of
samples and/or conditions, studying the separate and combined
impacts of each stage of digestion on the release and availability
of phytochemicals, which would hardly be possible in vivo.
A major obstacle for the interpretation of phytochemical bioac-
cessibility based on in vitro studies is the large number of published
models since the description of the 1st model developed for study-
ing iron bioaccessibility (Miller and others 1981). The diversity of
models has hampered the comparison of results across studies, and
increased the chances of finding contradictory results. The em-
ployed models mainly differ in the inclusion of various stages of
digestion (oral, gastric, small intestinal, large intestinal); digestion
times; pH; the nature of digestive enzymes involved; and concen-
trations of electrolytes and bile acids. Finally, while most of the
models are operated in static mode (that is, with prefixed con-
centrations and volumes of digested materials, enzymes salts, and
so on), there are also a limited number of dynamic models that
mimic the continuous changes of the physicochemical conditions,
and aim to better simulate the passage of the bolus/digesta through
the human digestive tract. However, these models are much more
labor- and cost-intensive than the static models.
The aim of this review is to summarize frequently employed
models for studying phytochemical bioaccessibility, to compare
conditions to the situation in vivo, and to suggest a set of variables
and values that appear closest to conditions in vivo, in order to
contribute to the standardization of in vitro models. One of the
major differences between the reported models, apart from being
static or dynamic, is their application to either hydrophilic or
lipophilic compounds (Figure 1).
For practical reasons, this review focuses on 2 major groups
of phytochemicals: polyphenols as the major hydrophilic phyto-
chemicals and carotenoids, as the major lipophilic phytochemicals;
aiming to elucidate factors affecting the choices of the appropriate
model for each application in order to simulate in vivo conditions
to the best of present knowledge. Thus, the review is structured,
1st, into a discussion on general aspects of digestion, and 2nd,
to provide more thorough insights into the individual digestion
phases themselves.
Parameters That Drive the Choice of Model
There are a number of factors that drive the choice of a model
system (Figure 1). The most important is the desired outcome of
the study. In some studies, the prime objective is to understand
the effect of simulated GI digestion on a certain class of phyto-
chemicals (hydrophilic or lipophilic). For a limited selection of
samples, in-depth simulation of a dynamic system may be more
appropriate as it allows simulation of the effects of multiple diges-
tive parameters on a small number of samples. Larger scale studies
may require screening of the effect of in vitro digestion on mul-
tiple samples (such as different source materials or the effects of
processing/cooking) and a relatively simple static model may be
more appropriate (Figure. 1).
In some cases, the function of in vitro digestion is to provide
samples that are more physiologically relevant for further stud-
ies on potential bioactivities, as with the preparation of “colon-
available” samples for investigating effects on colon cancer mod-
els (Brown and others 2012) or the preparation of dietary fiber
fractions such as β-glucans (Beer and others 1997).
Of course, there is considerable flexibility in the approaches.
Initial hypotheses could be tested in the static models and then
extended in dynamic model experiments. Insights gained from
dynamic models could be fed back into the design of more phys-
iologically appropriate screening methods (Figure 1).
Overview on Parameters Affecting the Release
and Chemical Changes of Lipophilic and Hydrophilic
Phytochemicals during Digestion
Digestion of phytochemicals is a complex process, and the
bioaccessibility of phytochemicals depends on both the charac-
teristics of the food matrix and the physiological conditions en-
countered in the various compartments of the GI tract (including
enzyme concentrations and pH). Additionally, the physicochem-
ical properties of the phytochemicals themselves are important
parameters. For example, the hydrophilicity/lipophilicity bal-
ance is crucial in driving the solubilization of hydrophilic phe-
nolic compounds into the aqueous phase of the intestinal di-
gesta and the restructuring of lipophilic carotenoids into mixed
micelles.
Since plant foods are often diverse in composition or eaten in
conjunction with other foods, food bolus constituents are likely to
modulate the bioaccessibility and stability of phytochemicals. This
may contribute to the rather small fraction of dietary phytochem-
icals that is typically absorbed and utilized by humans (Schramm
and others 2003). Therefore, defining the conditions that influ-
ence their absorption can provide significant insights into methods
for maximizing the utilization of these potential health-promoting
constituents. The main food components are proteins, carbohy-
drates, fiber, and fat, and their interactions with phytochemicals
are often not considered.When considering in vitro bioaccessibility
studies, chemical reactions (such as oxidation/reduction or com-
plexation), biochemical reactions (enzyme/substrate interaction),
or physical constraints (diffusion) occuring within food must be
taken into account. For polyphenols, in particular, these types of
interactions have rarely been taken into account when determin-
ing polyphenol digestion (Ortega and others 2009).
Lipophilic phytochemicals
The absorption of lipophilic phytochemicals mainly occurs after
the disruption of the food matrix, enabling the release and emul-
sification into lipid droplets in the stomach, followed by incorpo-
ration into mixed micelles. Although the lipophilic carotenoids
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Figure 1–Decision tree for choosing an in vitro digestion model: some a priori considerations. Major aspects concern lipophilicity of the phytochemical,
as well as amount sample material and number of samples.
are considered as relatively labile under acidic conditions, no
significant chemical modification in the human stomach has been
described (Tyssandier and others 2003). Some isomerization was
observed in the stomach of ferrets (Boileau and others 1999) and
relatively high recoveries of dietary carotenoids (65% to 91%) have
been observed after GI in vitro digestion (Granado-Lorencio and
others 2007; Failla and others 2009). The digestive stability of
carotenoids in different food matrices has been investigated in a
dynamic in vitro model (TIM 1) that simulates the stomach and
small intestine (Blanquet-Diot and others 2009; De ́at and others
2009). Zeaxanthin and lutein (xanthophylls) were found to be sta-
ble during the whole digestion, whereas lycopene and β-carotene
(carotenes) were stable in the gastric and duodenal compartments
but partly degraded in the jejunal and ileal compartments of the
small intestine, perhaps due to delayed release from the matrix and
later micellarization of these carotenes at this stage (Blanquet-Diot
and others 2009). Although an enhanced release from the matrix
can contribute to higher bioaccessibility, the released carotenoids
may be more susceptible to degradation and isomerization (Failla
and others 2008a). In the study by Blanquet-Diot and others
(2009), a degradation of β-carotene and all-trans lycopene, not
directly related with the formation of cis isomers, was observed in
the lowest part of the small intestine. As suggested by the authors,
the results might be due to breakdown to nondetected metabolites
(such as oxidation products) or enzyme–catalyzed cleavage prod-
ucts during small intestinal digestion, but no precise data could
support this hypothesis. Apart from the food matrix, carotenoid
bioavailability may be influenced by the presence of other nutri-
ents and nonnutrients within the food. For example, a competition
between carotenoids and other fat-soluble nutrients such as vita-
min E at the absorption stage has been reported (Faulks and others
1998). Differences in location and form will also affect carotenoid
release and bioavailability. Xanthophylls are often associated with
proteins, for example, lutein in green leafy vegetables is located
in chloroplasts, whereas carotenes are found in chloroplasts as oil
droplets, such as in fruits, or semicrystalline membrane-bound
solids like in carrot, tomato, and papaya (Faulks and others 1998;
Schweiggert and others 2012).
Garrett and others (1999) developed a modified method of the
in vitro digestion model to assess the transfer efficiency of pure
carotenoids from dietary lipids into synthetic mixed micelles. Sy
and others (2012a) found that lutein was more readily micel-
larized than the other carotenoids and especially compared with
lycopene, which was the least micellarized carotenoid. The ap-
parent poor solubility and bioaccessibility of lycopene may be
related to its elongated shape which could be responsible for the
molecule being extruded from the micelles into the surrounding
aqueous environment, and similar effects could be expected for
other lipophilic phytochemicals.
Hydrophilic phytochemicals
Phenolic phytochemicals can greatly vary in their chemi-
cal structure and properties, ranging from simple molecules
(such as phenolic acids) to highly polymerized molecules
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(proanthocyanidins) (Manach and others 2004). This chemodi-
versity results in different bioaccessibility. Factors in the bioacces-
sibility of polyphenols include their release from the food matrix,
particle size, their hydrophilic/lipophilic balance as related to their
glycosylation, different pH-dependent transformations (degrada-
tion, epimerization, hydrolysis, and oxidation within the GI tract),
and also interactions between polyphenols and food components
(Stahl and others 2002; Karakaya 2004). Phenolic compounds can
have strong affinities with human salivary proline- and histidine-
rich proteins and form both noncovalent and covalent associations
depending on the size of the phenolic compound (de Freitas and
Mateus 2001; Wroblewski and others 2001). High-molecular
weight polyphenols (such as tannins) can also interact strongly
with fibers and proteins, but their affinity is related to their size
and their solubility in water.
More hydrophobic phenolic compounds bind more strongly to
proteins (Le Bourvellec and Renard 2011). Laurent and others
(2007) investigated the behavior of phenolics from grape seed ex-
tract during in vitro digestion (with α-amylase from human saliva,
porcine pepsin, pancreatin, and bile extract), combined with a
Caco-2 cell model to evaluate the impact of brush border pro-
teins. Flavan-3-ol monomers ((+)-catechin and (−)-epicatechin)
and procyanidin dimers (B2 and B3) were stable during oral and
gastric digestion and polyphenols interacted with proteins from
both pancreatic secretions and brush border cells during the in-
testinal step. Simulated digestion of anthocyanins from, for ex-
ample, berries, red wine, and red cabbage have shown that these
compounds appear to be stable at the acidic conditions of the
stomach but less stable at the small intestinal pH (Gil-Izquierdo
and others 2002; McDougall and others 2005a, 2007). The total
recovery of anthocyanins from red cabbage was low (around 25%),
possibly due to degradation into new phenolic components by
the combination of the elevated pH and the presence of oxygen
during pancreatic digestion (McDougall and others 2007). Antho-
cyanins may be protected from degradation in the small intestine
by using encapsulation techniques, such as microcapsule systems
composed of amidated pectin with or without shellac coating or
whey proteins (Oidtmann and others 2012).
In summary, the digestive stability of carotenoids depends on
the molecular nature and the food matrix in which they are in-
cluded, with xanthophylls being more stable than carotenes. The
absorption of carotenoids depends on an efficient release from the
food matrix and subsequent solubilization in mixed micelles. By
contrast, micellarization is generally not required for cellular up-
take of phenolic compounds. However, some constituents such
as anthocyanins may be rapidly degraded due to increasing pH
(McDougall and others 2007) and the affinity of polyphenols for
proteins (Dangles and Dufour 2005, 2008) may lead to a major
modulation of both polyphenol absorption and reactivity in the
stomach and in the upper intestine.
Before Modeling: Considerations with Respect to Pre-
treatments, Meal Size, and Choice of Test Meals
According to food composition, the way it is processed and
the interaction of phytochemicals with other food components
(be they lipophilic or hydrophilic), the released amount of phy-
tochemicals from the food matrix may be altered and, therefore,
modify their bioaccessibility either by increasing or decreasing it.
Influence of the plant matrix and food bolus
Plant cell walls act as a barrier to digestion (Ellis and others
2004; Mandalari and others 2010). When a plant cell is broken
through mastication or crushing in industrial or domestic process-
ing, phytochemicals may associate with dietary fibers leading to
a modulation of their relative bioaccessibilities. In a recent study,
comparing the stability and bioaccessibility of carotenoids in pure
forms (synthetic β-carotene or retinyl palmitate solution) or from
food (carrot juice and raw or cooked spinach), Courraud and oth-
ers (2013) demonstrated that vitamin A and carotenoid standards
(synthetic β-carotene or retinyl palmitate solution) were unsta-
ble, whereas food carotenoids were generally better protected by
the food matrix (30% to 100% recovery compared with 7% to
30% for standards). Although, the susceptibility of carotenoids to
degradation and isomerization has been found to increase after
their release from the food matrix (Failla and others 2008b), inter-
actions with compounds released from the food matrix (including
soluble fibers) and the overall viscosity may affect their bioacces-
sibility (McClements and others 2008; Schweiggert and others
2012). For example, the bioaccessibility of β-carotene is known
to be influenced by strong binding to pectins (Ornelas-Paz and
others 2008).
Dietary fibers are the main carriers for phenolic compounds and
thus influence their bioaccessibility, as fiber-entrapped polyphe-
nols are both poorly extractable and barely soluble in the GI flu-
ids. High-molecular weight proanthocyanidins and hydrolyzable
tannins represent more than 75% of all food polyphenols ingested
(Arranz and others 2010) and may bind tightly to dietary fibers and
this restricts their accessibility. Soluble and insoluble polysaccha-
rides can bind phenolic compounds and limit their diffusion and
substrate–enzyme contacts during GI digestion while increasing
the viscosity of the medium (Eastwood and Morris 1992). During
the in vitro digestion of cocoa powder, protease and glycosidase
actions as well as microbiota activity were shown to influence the
release of flavanols from matrix fibers and proteins (Fogliano and
others 2011). Additionally, the extractability of phenolic acids,
flavonoids, and proanthocyanidins appeared to be improved in the
presence of fat, increasing by a 1.5 to 3 factor for cocoa liquor
(50% fat content) compared to cocoa powder (15% fat content)
(Ortega and others 2009).
The affinity of milk and egg proteins as well as gelatins for
polyphenols depends on both the protein and phenolic structures
(Bohin and others 2012). For example, chlorogenic acid associates
with milk caseins rather than with β-lactoglobulin, and this com-
plexation was relatively stable in simulated gastric and intestinal
steps (Dupas and others 2006). Despite these interactions, chloro-
genic acid absorption by Caco-2 cells and rats was not reduced
by milk addition to coffee. More than 60% of green tea flavanols
(such as epicatechingallate, epigallocatechin, and epigallocatechin-
gallate), which are very prone to oxidation, disappeared in the
intestinal phase during in vitro digestion (Haratifar and Corredig
2014). A protective effect was caused by the addition of pure ascor-
bic acid, by citrus juices, as well as by bovine, rice, and soy milks.
While ascorbic acid contribution reflects its superior antioxidant
capacity compared to tea flavanols, the protection by proteins was
partially reversed by increasing the content of digestive enzymes,
suggesting noncovalent interactions between bovine milk proteins
and galloylated tea flavanols (Green and others 2007).
Soy isoflavones appear to be more bioaccessible from fruit
juices and chocolate bars compared to cookies in in vitro con-
ditions, perhaps due to their lower diffusion rate from the car-
bohydrate/protein matrix of the cookies (de Pascual-Teresa and
others 2006). However, a complementary human intervention
study did not point out any significant difference in bioavailability
parameters (area under plasma-time curve, tmax or cmax) of these
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isoflavones. Similarly, the in vitro biacessibility of catechin was sig-
nificantly higher in beverages than in confections (Neilson and
others 2009). Higher amounts of isoflavones were also released
in vitro from custards thickened with starch rather than with car-
boxymethylcellulose (Sanz and Luyten 2006). This effect was at-
tributed to the hydrolysis of starch by α-amylase which occurs from
the mouth to the intestine. Finally, bile salts were critical to im-
prove the in vitro bioaccessibility of isoflavone aglycones from soy
bread through micellarization of these poorly soluble molecules
(Walsh and others 2003).
Impact of processing
Previous studies (Garrett and others 1999) have indicated
that food processing and presence of dietary fat can enhance
carotenoid bioaccessibility. Cooking and heat treatment may en-
hance carotenoid bioaccessibility due to disruption of plant tissue
and denaturation of carotenoid–protein complexes which enhance
release from the food matrix (Veda and others 2006; Failla and oth-
ers 2009; Aherne and others 2010). However, cooking enhanced
the bioaccessibility and bioavailability of all-trans β-carotene
but also caused carotenoid isomerization (Aherne and others
2010).
There are many reports describing that thermal processing im-
proves lycopene bioaccessibility due to the breakdown of the
tomato matrix (Gartner and others 1997; Porrini and others
1998; Van Het Hof and others 2000). However, depending on
the processing methods, differences in lycopene bioaccessibility
have been reported. Karakaya and Yilmaz (2007) reported that
lycopene bioaccessibility in raw tomato (29%) and canned tomato
(22%) was similar. On the other hand, the bioaccessibility of
lycopene from sun-dried tomatoes reached 58% (Karakaya and
Yilmaz (2007). High-pressure homogenization (HPH) and HPH
combined with heat processing (90 °C for 30 min) caused a de-
crease in the in vitro bioaccessibility of lycopene. In addition, an
inverse relationship between the homogenization pressure and ly-
copene in vitro bioaccessibility was reported (Colle and others
2010). It was suggested that the fiber network formed by HPH-
entrapped lycopene is not so accessible to digestive enzymes and
bile salts. High-pressure processing (HPP), however, had no effect
on α-carotene and β-carotene bioaccessibility in carrots. In green
beans, lutein bioaccessibility was increased by a pressure treatment
at 600 MPa while for β-carotene, an HPP treatment, either at 400
or 600 MPa, reduced its bioaccessibility (McInerney and others
2007), which suggests effects due to the matrix and compound
structure.
In wheat bran, ferulic acid and para-coumaric acid are mostly
bound to arabinoxylans and lignin and are thus insoluble, whereas
sinapic acid is mainly found in soluble conjugate forms esterified
to sugars and other compounds. It was reported that the bioacces-
sibility of sinapic acid from bran-rich breads was much higher than
that of ferulic acid and para-coumaric acid (Hemery and others
2010). Food processing, especially grinding of the bran fractions,
increased the bioaccessibility of phenolic acids (Hemery and oth-
ers 2010). Increased bioaccessibility was correlated to the presence
of very small particles (diameter < 20 μm) for sinapic acid and
ferulic acid and to larger particles for para-coumaric acid (between
20 and 100 μm). Additionally to particle size reduction, exoge-
nous ferulase and xylanase treatments contributed to the pool of
free and exposed ferulic acid residues as demonstrated by the in-
creased antioxidant capacity displayed by treated fractions in an in
vitro model of digestion (Rosa and others 2013a, 2013b).
Impact of starting meal size
Adjustment of the ratio of the amount of the test meal to water
present in order to mimic dietary bolus during digestion phases
has an impact on viscosity. This ratio, along with particle size,
are important factors influencing phytochemical release during
digestion.
During transit in the oral cavity, the stomach, and the small in-
testinal compartments, the dietary bolus will be diluted as a con-
sequence of addition of saliva and other secretions. The amount
and type of food influence the composition and secretion rates.
Apart from the volume and composition of the secretions, me-
chanical forces will also have an impact on the disintegration and
dissolution of a meal and on the rate of transfer through the GI
tract. In general, dynamic models are able to process complex
foods through mechanical and enzymatic digestions at volumes
equivalent to “standard” meals.
Digestion Models for Studying Phytochemical
Bioaccessibility—Static Compared with Dynamic
Models
Depending on the type of research question, for example, if
constituting a screening application or a confirmative study, the
type and amount of sample present, static or dynamic in vitro
models can be used to simulate different phases of digestion
(Figure 1). Practically, static models provide a feasible and inex-
pensive means to assess multiple experimental conditions, allowing
large numbers of samples to be tested. Dynamic multistage con-
tinuous models facilitate long-term studies and probably come
closest to in vivo conditions. These complex computer-controlled
systems, however, are expensive to set up, more labor intense and
time consuming (maximum 1 experiment/d), and require higher
operating costs in terms of working volumes and continuous ad-
dition of substances mimicking GI fluids.
Static models
The simulation of the digestive process can be divided into
2 major stages: simulating gastric and small intestinal digestions,
with conditions generally based on the method described byMiller
and others (1981). Adaptations to this model have been made to
modify the conditions and the procedures for studies of digestibil-
ity and bioaccessibility of phytochemicals, but the “physiological
conditions” chosen vary considerably across different static in vitro
studies.
The comparative simplicity of static methods have allowed their
adaptation to measuring the bioaccessibility of many phytochem-
icals from various fruits and vegetables, including phytosterols
(Bohn and others 2007), glucosinolates (Iori and others 2004),
carotenoids (Garret and others 1999; Failla and others 2008b),
and many types of polyphenols (Gil-Izquierdo and others 2002).
This simplicity allows the running of multiple samples in paral-
lel. However, contrary to dynamic models, these static models
cannot take into account dynamic physiological responses to the
introduction of a food bolus, such as pH increase and following
decrease in the stomach, and enzyme secretions in response to the
food bolus introduced (Isenman and others 1999).
However, adaptations of the static model have been carried
out for the investigation of various phytochemicals, such as ul-
tracentrifugation and/or filtration, to study the micellar phase
of lipophilic constituents. While this is normally not done for
polyphenol bioaccessibility, additional steps such as dialysis have
occasionally been introduced (Bouayed and others 2012).
C© 2014 Institute of Food Technologists® Vol. 13, 2014  Comprehensive Reviews in Food Science and Food Safety 417
In vitro models for bioaccessibility and digestion studies . . .
Dynamic models
Compared to static models, dynamic models have the ad-
vantage that they can simulate the continuous changes of the
physicochemical conditions including variation of pH from the
mouth to the stomach and the intestine, altering enzyme secre-
tion concentrations, and peristaltic forces in the GI tract.
Different dynamic gastric models (DGMs) have been developed
and designed for detailed measurement of gastric biochemistry and
mixing. Due to their closer resemblance to in vivo conditions, but
much lower throughput, they are more suitable to confirm results
obtained in static models and to gain more detailed insights into
changes occurring during digestion. The DGM, developed at the
Inst. of Food Research (Norwich, U.K.), is composed of 2 suc-
cessive compartments (Vardakou and others 2011). The model re-
produces gastric emptying and secretion according to data derived
from echo-planar magnetic resonance imaging and the rates of
GI digestion obtained from human studies (Golding and Wooster
2010). The system was originally constructed to assess the impact
of the 1st stages of digestion on the bioaccessibility and delivery
profiles of nutrients to the duodenum. It simulates the physical
mixing, transit, and breakdown forces (including flow, shear, and
hydration), pH gradients, and gastric secretions.
The human gastric simulator (HGS), a model developed at the
Univ. of California-Davis is composed of a latex chamber sur-
rounded by a mechanical driving system to effectively mimic the
frequency and intensity of the peristaltic movements in the stom-
ach (Kong and Singh 2010). HGS is designed to mimic the gastric
shear forces and stomach grinding. This appears to be important
for bioaccessibility studies as the rate of release of phytochemicals,
from fibrous particles, into the surrounding intestinal fluid is in-
versely proportional to particle size and directly proportional to
phytochemical gradient. It is furthermore affected by the physical
state of the phytochemical, the physical structure, and the surface
properties of the particle (Palafox-Carlos and others 2011). To al-
low closer simulation of in vivo physiological processes occurring
within the lumen of the stomach and small intestine, some of the
main parameters of digestion (such as peristaltic mixing and transit,
secretions, and pH changes) have been applied in some models.
The TNO gastrointestinal model (TIM-1) developed by TNO in
Zeist (the Netherlands), has been used for a broad range of stud-
ies (Minekus and others 1995). The system consists of 4 different
compartments, representing the stomach, duodenal, jejunal, and
ileal parts of the GI tract. Each compartment is composed of 2
glass jackets lined with flexible walls. The TIM-1 system enables
simulation of gastric emptying rate, peristaltic movements, and
transit time through the small intestine and gradual pH changes in
the different compartments (Minekus and others 1995). This has
given useful information on the parameters affecting the release
and digestive stability of carotenoids from different food matri-
ces through the GI tract (Blanquet-Diot and others 2009). This
model has also been extensively used to assess both folate and folic
acid bioaccessibility from foods (O¨hrvik 2008; O¨hrvik and others
2010).
For polyphenols, there is limited evidence as to which method
is the most appropriate for measuring bioaccessibility, espe-
cially as it has become clear that the colon is greatly involved
in the metabolism and absorption of these compounds (Bolca
and others 2012; Czank and others 2013; Ludwig and oth-
ers 2013; Pimpa˜o and others 2014). Thus, both static and dy-
namic models, which do not take into account the simulation
of the colon, have limitations in predicting the bioavailability
of polyphenols. However, with the development of additional
models aiming to simulate colonic fermentation, such as the
TIM-2 model, the nonbioaccessible fraction following gastric and
small intestinal digestion may be studied, as demonstrated for
phenolic compounds in wheat bread (Mateo Anson and others
2009).
An adapted model of TIM-1, a computer-controlled GI model
called Tiny-TIM, has more recently been used to assess the bioac-
cessibility of phenolic acids in breads (Hemery and others 2010).
The model is a simplified and downscaled TIM-1 for rapid screen-
ing. The main characteristics of the system are the same as for
TIM-1, but instead of 4 compartments, the Tiny-TIM model
consists of 2 compartments that represent the stomach and the
small intestine. The results were found to be consistent both with
the data from a previous study evaluating the bioaccessibility of
phenolic acids in TIM-1 (Kern and others 2003) and a human
study (Mateo Anson and others 2009). To our knowledge, except
for the comparison between the results obtained in the TIM-1 and
Tiny-Tim models, so far no comparisons between the different
dynamic models have been made.
Setting Up the Model
Simulation of the oral phase
The oral cavity is the portal of entry of nutrients and has been
considered a “bioreactor” (Gorelik and others 2008; Mathes and
others 2010; Ginsburg and others 2012). Saliva is constituted by
more than 99% water, being a very dilute fluid. It contains a va-
riety of minerals, various proteins (the major being the mucin
glycoproteins, albumin, and digestive enzymes), and nitrogenous
compounds such as urea and ammonia (Ginsburg and others 2012).
An intensive mixing of simulated saliva and the introduced food
bolus is usually desired, typically in a ratio of 1:1, keeping in mind
practicality and the basal flow of saliva during ingestion, estimated
at 1 to 3 mL/min (Engelen and others 2003). An ingested food or
beverage undergoes a number of chemical, biochemical, and me-
chanical processes in the mouth, although this is less significant for
liquids due to short residence time. Components may be subject
to changes in pH, ionic strength, and temperature, action of var-
ious digestive enzymes (notably lingual lipase, amylase, protease);
interactions with biopolymers in the saliva (mucin); interactions
with sensory receptors of the tongue and mouth; and particle size
reduction of bolus by chewing (mastication). These are all major
factors to take into consideration when designing an in vitro di-
gestion step that simulates the human mouth (McClements and Li
2010).
Particle size reduction. A few studies have paid attention to
how mechanical breakdown during the oral phase affects phy-
tochemical bioaccessibility. Mastication consists of grinding food
into smaller pieces and imbuing them with saliva, this constitutes
the bolus that will be swallowed. By increasing the surface area
of hydration and accessability to the action of digestive enzymes,
overall digestion efficiency and GI absorption of phytochemicals
will increase (Kulp and others 2003). A partial and short chewing
of vegetables might influene the availability of major phytochemi-
cals present. However, the interindividual variability in the particle
size of food boluses at the end of chewing has been considered
to be insignificant for overall bioaccessibility (Woda and others
2010), and the use of 1 individual to chew the meal and expec-
torate it prior to swallowing was found to be acceptable (Ballance
and others 2013). However, further studies are needed to confirm
that 1 subject is a practice acceptable for investigating the effect
of mechanical breakdown on phytochemical bioaccessibility dur-
ing the oral phase. When studying bioaccessibility of carotenoids,
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techniques such as grinding or homogenizing, with a stomacher
laboratory blender for different intervals in the presence of artificial
saliva, were compared with physically masticated foods by humans
(Lemmens and others 2010). The average particle size distribu-
tion after human chewing was investigated and this information
was used to simulate average mastication in vitro by a blending
technique.
To produce food boluses with properties similar to those re-
sulting after natural chewing, the Artificial Masticatory Advanced
machine (AM2) has been developed and validated against human
subjects chewing raw carrots (cylindrical sample height 1 cm, di-
ameter 2 cm, 4 g) and peanuts (3.5 g) (Mishellany-Dutour and
others 2011). It was concluded that AM2 produces a food bo-
lus with similar granulometric characteristics to human chewing,
although no bioaccessibility parameters for phytochemicals were
evaluated.
Chemical and biochemical processes. Due to the usually very
short interaction of oral enzymes with the food bolus prior to
reaching the stomach, their influence is much less clear and rather
limited to carbohydrate-rich foods such as cereal-based foods (Hur
and others 2011). For example, it is estimated that nearly 5% of
the consumed starch is already degraded in the mouth cavity by
salivary amylase (Guyton and Hall 1996). Usually, in vitro methods
are initiated using α-amylase at pH around 7 (Table 1).
Ginsburg and others (2012) suggested an important role of saliva
in the solubilization of polyphenols present in fruits and plant
beverages which substantially increases their availability. More-
over, saliva can enhance adherence of polyphenols to oral surfaces,
prolong retention in the oral cavity, and thus contributes to the en-
hancement of the redox status of the oral cavity. Salivary albumin,
mucins, and proline-rich proteins may be of particular importance,
affecting the digestibility and absorption of specific polyphenols,
for example, tannins may be precipitated by such proteins (Bennick
2002) through hydrogen bonding and hydrophobic interactions.
In summary, an oral digestion phase is recommended for
carbohydrate-rich foods. Alternatively, starting with particles of
small size (50 to 1000 μm) may be appropriate, as this mimics
the particle size following the chewing process for vegetables and
fruits (Hoebler and others 2000; Lemmens and others 2010). If
oral digestion is omitted, dry samples may be introduced at a ra-
tio of approximately 1:4 (food:liquid), considering common meal
sizes of approximately 200 to 300 g and a gastric juice volume of
about 1 L (Sergent and others 2009). A fluid of physiological salt
concentration (such as saline) should be employed.
Simulation of the gastric phase
The knowledge of disintegration of food inside the stomach is
crucial for assessing the bioaccessibility of phytochemicals for both
static and dynamic methods. Food disintegration in the stomach
is a complex process including mechanical actions and activity of
gastric fluids.
Gastric juice contains hydrochloric acid (HCl), pepsinogens,
lipase, mucus, electrolytes, and water. The rate of secretion varies
from approximately 1 to 4 mL/min under fasting conditions to
between 1 and 10 mL/min after food intake (Wisen and Johansson
1992; Brunner and others 1995). The presence of HCl contributes
to the denaturation of proteins and it activates pepsin.
Peristaltic waves originating from the stomach participate to
the size reduction of solid foods down to a diameter of 1 to
2 mm (Kong and Singh 2010). Stomach emptying is a critical
step in the digestion process. Several factors may influence the
gastric emptying of food and fluids including volume, viscosity,
and pH. The speed of the emptying of liquid meals is directly
proportional to the volume present in the stomach. Solid foods are
emptied more slowly, in a biphasic pattern with a lag phase during
which little emptying occurs, followed by a linear emptying. The
duration depends on the physical properties and approximately 3
to 4 h are needed for a complete emptying of the stomach (Schulze
2006).
A nutrient-driven feedback regulation from the small intestine,
limiting the gastric emptying to a maximum of about 3 kcal/min
has been suggested (Lin and others 2005; Kwiatek and others
2009), while other data point to a nutrient-dependent empty-
ing pattern with emulsified fat emptying faster than glucose and
proteins (Goetze and others 2007). Furthermore, the presence of
dietary fibers is known to slow down gastric emptying of complex
meals (Marciani and others 2001).
pH. The gastric pH in the fasted state in healthy human sub-
jects is in the range of 1.3 to 2.5. The intake of a meal gener-
ally increases the pH to above 4.5 depending on the buffering
capacity of the food. For example, in nasogastrically intubated
humans fed a western-type diet enriched in either tomato, or
spinach or carrot purees, the stomach pH sharply increased to
approximately 5.4 to 6.2 after meal intake, then continuously de-
creased to reach approximately 1.8 to 2.9 after 3 h of digestion
(Tyssandier and others 2003).Similarly, after ingestion of a cocoa
beverage, the gastric pH reached 5.4 within 3 min before re-
turning to the baseline pH of 1.9 (Rios and others 2002). Most
static in vitro studies have been conducted at a pH below 2.5,
which are conditions related to the human fasting state rather
than to real food digestion. Only a few authors have considered
as relevant a pH of 4 associated with the midstep of digestion
(Reboul and others 2006; Dhuique-Mayer and others 2007). The
change of gastric pH is, however, taken into consideration in dy-
namic models as shown for the digestion of tomato carotenoids
in the TIM system (pH 6 to 1.6) (Blanquet-Diot and others
2009).
Enzymes. Pepsin, which is readily available as porcine pepsin,
has been integrated in most in vitro models of gastric digestion,
although in varying amounts (Table 2). Pepsin content should
be assessed as enzymatic activity per weight of protein for the
sake of comparison. Gastric lipase is usually omitted even though
lipolysis in the human stomach by gastric lipase is known (Carriere
and others 1993; Armand and others 1994). Most of the lipids
from diet are present as emulsified droplets, with diameters in the
range of 20 to 40 μm, and it was suggested that gastric lipolysis
can help to increase emulsification in the stomach (Armand and
others 1994), which would thus enhance lipophilic phytochemical
bioaccessibility. Human gastric lipase secretion ranged from 10 to
25mg/3 h and the percentage of intragastric lipolysis during gastric
digestion was 5% to 40% (Carriere and others 1993; Armand 2007)
and primarily occured within the 1st h of digestion (Armand and
others 1994).
Because human gastric lipase is unavailable, fungal lipases from
Aspergillus niger or Aspergillus oryzae have been used, as in the TIM
model. However, A. niger lipase has a wide pH optimum of 2.5 to
5.5 compared to 4.5 to 6 for human gastric lipase (Carriere and
others 1993). The fungal lipase can hydrolyze both the sn-1 and sn-
3 positions of the triacylglycerol molecule, with a slight preference
for the sn-1 position, whereas gastric lipase is most active at the sn-
3 position (Van Aken and others 2011). Alternatively, a mammalian
lipase such as rabbit gastric lipase could be used as Capolino and
others (2011) demonstrated that its specificity is close to that of
human lipase. At the present time, a combination of rabbit gastric
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Table 1–Concentrations of enzymes and concentrations employed during the oral phase of in vitro (A) and human studies in vivo (B) studies.
A—In vitro studies
α-Amylase pH of Time of
Type of study activity (U/mL)a digestion digestion (min) Temperature (°C) Study/reference
Digestion of grape seed flavonoids
(human saliva)
Not specified 6.9 10 37 (Laurent and others 2007)
Digestibility of soya bean, cowpea,
and maize
Approximately 1 7 30 37 (Kiers and others 2000)
Bioactivity of wheat bread; changes
in the antioxidant activities of
vegetables
200 6.75 10 37 (Gawlik-Dziki 2009, 2012)
Developing digestion procedure with
mammalian enzymes
25 to 125 7 15 37 (Lebet and others1998)
β-Carotene micellarization 900 6.5 ± 0.2 10 37 (Thakkar and others 2007)
β-Carotene bioacessibility 300 6.7 to 6.8 10 to 15 37 (Bengtsson and others 2009, 2010)
β-Carotene bioaccessibility (human
saliva from n= 9)
12.5b 6.7 to 6.9 10 37 (Schweiggert and others 2012)
β-Carotene bioaccessibility from
sweet potato
35 7.0 10 37 (Poulaert and others 2012)
Polyphenol release during digestion 150 6.9 10 37 (Tagliazucchi and others 2012)
B—Human studies (in vivo)
α-Amylase Time of
Type of study activity (U/L)c digestion (min) pH Study/reference
Studying impact of saliva process on
lipophilic polyphenol availability
Not specified 0.5 Nd (Ginsburg and others 2012)
Physiology of human saliva including
mucin and electrolytes
Not specified Nd 7.0 (Aps and Martens 2005)
Human salivary α-amylase activity 4 to 1653, mean 284b Nd Nd (Suska and others 2012)
List of reference values 60 to 282, mean 170d Nd Nd (Jakob 2008; Kopf-Bolanz and others
2012)
Stress and α-amylase 220 to 500 between 8 am and 8 pm.d Nd Nd (Nater and others 2010)
Oral digestion of cereals by humans 52 to 77(basal) 58 to 66(with cereals)b 5 7.1 ± 0.1 (Hoebler and others 1998)
Saliva activity measurements 190d Nd Nd (Rohleder and Nater 2009)
a“Sigma units,” unless stated otherwise: 1 unit will liberate 1 mg maltose from starch in 3 min at 20 °C at pH 6.9. Often done via the dinitrosalicylic acid (DNS) color assay (540 nm). Conversion to IFCC and
Phabedas: when substrate is expressed as same mass unit (mmol not mg), 1 DNS unit = approximately 2.5 IFCC units (Bassinello and others 2002). For results given in mg, conversion factor from DNS to IFCC is
×2.5/342 = ×0.0073.
bPhabedas (Magle AB, Lund, Sweden) test: blue color from starch breakdown measured at 620 nm. Conversion from μkat to U according to http://www.phadebas.com/data/phadebas/
files/document/Instructions_Phadebas_Amylase_Test.pdf, 60 U = 1 μkat
cUnits are expressed here in final volume of salivary fluid. One unit will cleave 1 μmol glucosidic linkage from starch per minute, however substrate may differ. Both methods presented here (IFCC EPS [ethy-
lene protected substrate] and Phabedas) yield comparable results
dReleases 1 μmol/min p-nitrophenol from 4,6-ethyliden-G7-p-nitrophenol-D-maltoheptasoid (ethylidene-G7PNP), measured at 405 nm. 60 U = 1 μkat [IFCC EPS method]).
Nd, no data.
lipase and porcine pancreatic extract is favored to simulate GI
lipolysis in vitro.
Oxygen, dietary iron, and antioxidant activity of phytochemi-
cals and micronutrients. The presence of other food components
may alter polyphenol and carotenoid stability in the gastric tract.
After food intake, lipid oxidation may occur due to the close
contact between dietary iron, dioxygen, and emulsified lipids.
This was demonstrated for heme (metmyoglobin) and nonheme
iron (FeII/FeIII) forms in emulsion systems modeling the phys-
ical state of triacylglycerols (Lorrain and others 2012). Dietary
polyphenols such as rutin, (+)-catechin, and chlorogenic acid
proved to be better inhibitors of the metmyoglobin-initiated lipid
oxidation than α-tocopherol and vitamin C (Lorrain and others
2010). The antioxidant activity of polyphenols depended on an
emulsifying agent (for example, proteins, phospholipids) and pH.
In this process, polyphenols were consumed, giving rise to oxi-
dation products which themselves retained antioxidant properties
(Lorrain and others 2010). Lycopene and β-carotene proved to
be less efficient inhibitors of lipid oxidation compared to bacterial
carotenoids (mainly glycosylated apolycopenoids) (Sy and others
2012b). Phenolic compounds and carotenoids had complemen-
tary mechanisms of action: the former inhibited the initiation step
of lipid peroxidation by reducing the prooxidative FeIV species
of myoglobin while the latter inhibited the propagation phase by
direct scavenging of the lipid peroxyl radicals. Oxygen may thus
impact phytochemical and micronutrient stability in the gastric
tract. The level of dissolved O2 increases during mastication of
food (Gorelik and others 2005) but the oxygen partial pressure
gradient dropped markedly from the proximal to the distal GI
tract in living mice from 58 torr in the midstomach, 32 torr in the
midduodenum, 11 torr in the midsmall intestine and midcolon
to 3 torr in the distal sigmoid colon–rectal junction (compared
to 160 torr for O2 in air) (He and others 1999). For this reason,
some authors suggested flushing with nitrogen or argon for a few
minutes to reduce the levels of dissolved O2 prior to initiation of
simuated digestion (Bermudez-Soto and others 2007).
Static models. Static modeling of gastricdigestion of phyto-
chemicals is basically conducted by a pepsin hydrolysis of homog-
enized samples under fixed pH and temperature for a period of
time. The internal body temperature (37 °C ) is generally used.
Dynamic processes occurring during human digestion such as me-
chanical forces or continuous changes in pH and secretion flow
rates are usually not reproduced (Guerra and others 2012). There
are many studies on in vitro digestion of phytochemicals using static
models, differing to some extent (Table 2). The major differences
among the methods used for modeling the gastric phase of di-
gestion are (1) addition or absence of phospholipid vesicles; (2)
addition or absence of lipase; (3) incubation time between 0.5 and
2 h; (4) pH varying from 1.7 to 2.5; and (5) pepsin to substrate
ratio.
For highly processed plant matrices, it appears that the large
majority of polyphenols is already released in the gastric phase.
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Table 2–Typical concentrations of gastric enzymes in human studies and in vitro experiments.
A—In vitro studies
Pepsina Pepsin activitya pH of Time of
Type of study (mg/mL) (U/mL) digestion digestion (min) Study/reference
Bioavailability of iron Approximately 5 4000 to 12500 2.0 120 (Miller and others 1981)
Bioaccessibility of carotenoids 2.3 1800 to 5600 2.0 60 (Biehler and others 2011a, 2011b)
Bioaccessibility of carotenoids 2.2 1700 to 5400 2.0 60 (Garrett and others 1999)
Bioaccessibility of carotenoids 1.7 1400 to 4300 2.0 60 (Hedre´n and others 2002)
Bioaccessibility of carotenoids 1.2 900 to 3000 4.0 30 (Dhuique-Mayer and others 2007)
Bioaccessibility of carotenoids 1.0 800 to 2500 2.0 60 (Liu and others 2004)
Bioaccessibility of carotenoids 3.0 2400 to 8300 2.0 60 (Yonekura and Nagao 2009)
Bioaccessibility of polyphenols Nd 315 to 350 2.0 120 (Gil-Izquierdo and others 2002)
Bioaccessibility of polyphenols 2.2 1800 to 5600 2.0 to 2.5 60 (Bouayed and others 2011)
Bioavailability of polyphenols 16 15600 2.0 120 (Cilla and others 2011)
Bioavailability of polyphenols Nd 158 2.0 120 (Tagliazucchi and others 2012)
Bioavailability of polyphenols Approximately 0.1 315 1.7 120 (McDougall and others 2005a, 2005b)
B—Human studies (in vivo)
Fluid investigated Gastric residence
and type of study Pepsin (U/mL) time (h) pH Study/reference
Digestion in adults 942b (6877)a(basal) Nd Nd (Armand and others 1995)
Digestion in infants Approximately 85b (621)a
(pp); 190b (1387)a(basal)
Nd Nd (Armand and others1996a)
Helicobacter pylori impact on
stomach
47c(174)a Nd 1.41 (basal) (Feldman and others 1998)
18 Individuals, fasting juice 37 ± 21 (7 to 70)d (3700)a Nd 1 to 4, median 2 (basal) (Ulleberg and others 2011)
Pepsin inhibitors in humans 20 to 260 μg/mLe Nd Nd (Pearson and Roberts 2001)
Measurement gastric
secretion
Nd Nd 1.1 (basal); 3.5 (60 min. pp)
2.0 (120 min. pp)
(Gardner and others 2002)
Characterization of digestive
fluids
110 to 220 μg/mL (basal)e;
260 to 580 μg/mL (pp)
Nd 2 (basal); 6 (60 min. pp); 5
(120 min. pp)
(Kalantzi and others 2006)
Helicobacter pylori impact on
pepsin
114 to 1030 μg/mLe Nd 2.4 (basal) (Newton and others 2004)
Gastric residence time, solid
meal
Nd 3.5 ± 0.7 Nd (Mojaverian and others 1988)
Gastric residence time of
capsule
Nd 1.2 ± 0.45 1.5 ± 0.04 (basal) (Mojaverian 1996)
Gastric passage time of
capsule
Nd 1.0 Nd (Worsoe and others 2011)
Digestability of rice pudding Nd 65% complete (1.5 h) Nd (Darwiche and others 1999)
a“Sigma units,” pepsin typically used: 800 to 2500 units/mg such as by Sigma-Aldrich. One unit will produce a change in absorbance of 0.001 at 280 nmat 37 °C, in 1min, at pH2.0, with hemoglobin as substrate.
bOne pepsin unit has been defined as the amount of enzyme required to produce an absorption of 0.073 at 37 °C in 10 min at pH 1.8 from a 2% hemoglobin solution. One unit equivalent to approximately 7.3
“Sigma units” based on Armand and others (1995), assuming a specific absorption coefficient of tyrosine of 1250 (l/[mol × cm]).
cMeasured as international units, with 1 IU = 3.7 Anson units.
dOne unit of enzyme activity was defined as the amount (in mL) of gastric or duodenal juice giving a difference in absorbance of 1.0 at 280 nm at 37 °C and pH 3.0, in 10 min, with hemoglobin as substrate. One
unit equivalent to approximately 100 “Sigma units.”
eμg enzyme/mL.
Nd, no data; pp, postprandial; min.pp, minutes postprandial.
Indeed, polyphenol bioaccessibility from fruit juices, wines, green
tea, or phenolic extracts, in the presence of simulated gastric juices
(pH 1.7 to 2.5, pepsin, 1 to 4 h) was nearly 100% (Perez-Vicente
and others 2002; McDougall and others 2005a; McDougall and
others 2005b; Bermudez-Soto and others 2007; Green and others
2007; McDougall and others 2007; Gumienna and others 2011)
but can be only between 30% and 100% from solid matrices such
as homogenized peaches, apple, grape berries, cherries, or carob
flour (Fazzari and others 2008; Bouayed and others 2011; Ortega
and others 2011; Tagliazucchi and others 2012).
Among phenolic compounds, apple flavanols (epicatechin
and procyanidin B2), aswell as chokeberry proanthocyanidin
oligomers, were more degraded than caffeoylquinic derivatives,
flavonols, or anthocyanins. Cocoa proanthocyanidins (trimers to
hexamers) and apple procyanidin B2 were shown to undergo de-
polymerization in a simulated gastric juice (37 °C, pH 1.8 to
2.0) (Spencer and others 2000; Kahle and others 2011), whereas
in vivo, this degradation was not validated, mainly because the
stomach pH increased to 5.4 after the ingestion of the cocoa bev-
erage and progressively decreased to the basal value as the stomach
emptied (Rios and others 2002).
Certain epoxycarotenoids, such as violaxanthin and neoxanthin
from spinach, were shown to undergo epoxide–furanoid transi-
tions at pH 2 (Biehler and others 2011b). This transformation
extent may clearly depend on the gastric acidity and time of
exposure.
Dynamic models. DGMs of digestion incorporate (1) mixing
of the nonhomogeneous gastric digesta as simulated by peristaltic
movements in the HGS model (Kong and Singh 2010), (2) acid-
ification, (3) addition of gastric enzymes, and (4) delivery to the
duodenum (Chen and others 2011). Usually, computer-controlled
protocols are designed to deliver secretions and chyme (digesta) in
the normal physiological range. Dynamic models are described in
more detail in the previous section “Digestion models for study-
ing phytochemical bioaccessibillity.” Up to now, few studies have
been reported for phytochemicals in dynamic models compared
to the numerous data in static models. For example, in the TIM-
1 system, tomato (E)-β-carotene and (E)-lycopene proved to be
stable, although the recovery yield was modulated by the tomato
matrix (Blanquet-Diot and others 2009). The Tiny TIM-1 system
was used to evaluate the bioaccessibility of phenolic acids in breads
(Hemery and others 2010). The amount of bioaccessible phenolic
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acids was enhanced by using finer particles in wheat bran-rich
breads (Hemery and others 2010).
General considerations. The effective release of the phenolic
compounds in the stomach maximizes the potential for absorp-
tion in the small intestine. For lipophilic compounds, such as for
carotenoids, such comparisons are less meaningful, as the forma-
tion and incorporation of the mixed micelles are mostly achieved
during the small intestinal stage.
In summary, several major aspects deserve consideration during
the gastric digestion, including the limitation of oxygen, either
by flushing with inert gasses or by reducing the headspace vol-
ume to a minimum, the inclusion of gastric lipase, especially for
lipid-soluble compounds, and a sufficient protein degradation ca-
pacity to allow release of phytochemicals. An initial low pH (<3)
is not physiological and should be avoided due to nonoptimal
functioning of enzymes, especially of lipase.
Simulation of the the small intestinal phase
After food disintegration in the mouth and stomach, the main
enzymatic digestion and absorption of nutrients takes place in
the small intestine. After stomach digestion, the acidic chyme
is delivered to the small intestine and neutralized with sodium
bicarbonate to give an appropriate pH for enzyme activities. The in
vitro small intestinal digestion of phytochemicals generally involves
mimicking pH, temperature, time, and pancreatic juice including
electrolytes, bile salts, and enzymes.
pH, enzymes, and bile salts. In the fed state, pH can vary from
5.4 to 7.5 in the duodenum (Tyssandier and others 2003; Kalantzi
and others 2006; Clarysse and others 2009), to 5.3 to 8.1 in the
jejunum (Lindahl and others 1997; Perez de la Cruz Moreno and
others 2006), and up to 7.0 to 7.5 in the ileum (Daugherty and
Mrsny 1999) (Table 3).
Pancreatic enzymes, including proteases, amylases, and lipases,
act together with other digestive enzymes (such as maltase, lac-
tase, α-dextrinase, and peptidases) produced by the brush border
[a microvillus membrane at the luminal surface of the small in-
testine (Holmes and Lobley 1989)], in the breakdown of food
constituents.
In vivo, bile salt concentrations were found to be higher in the
fed state (3 to 12 mM range) than in the fasted state and variable
between duodenum and jejunum (Table 3).
The major differences among the methods are the forms of
enzymes (pancreatin or individual enzymes) and biliary acids
used (bile salt mixtures, real fresh bile, or individual bile salts)
(Table 3). Very few models use individually prepared bile salts
and enzymes (including porcine pancreatic lipase, porcine col-
ipase, porcine trypsin, bovine chymotrypsin, and porcine amy-
lase), although this may give better control over enzymatic activity
(Mandalari and others 2010). Several studies have reported that
the presence of bile salts and pancreatic enzymes is essential for
the efficient micellarization of lipophilic compounds (Garrett and
others 1999; Hedre´n and others 2002; Wright and others 2008;
Biehler and others 2011a). In the study by Biehler and others
(2011a), carotenoid micellarization from spinach was strongly re-
duced in the absence of pancreatin and bile salts, while it was not
significantly impacted by the omission of pepsin during gastric
digestion. Minimal bile salt concentration of 2.4 mg/mL (about
5 mM), within the in vivo concentration range, was required for
optimal transfer of lutein and β-carotene from lipid droplets into
mixed micelles (Garrett and others 1999; Wang and others 2012).
The maximum β-carotene transfer was obtained at pH 6, which
reflects the optimal pH for the activity of pancreatic lipase, and
with a pancreatic lipase concentration of 0.4 mg/mL (Wang and
others 2012). At higher bile salt concentrations, β-carotene mi-
cellarization could depend on the activity of pancreatic colipase-
dependent lipase (Wright and others 2008). For polyphenols, the
hydrophilic forms such as glycosylated flavonols or quinic acid
derivatives of hydroxycinnamic acids may readily solubilize in the
aqueous phase whilst less soluble flavonoid aglycones or procyani-
dins may bind to dietary fibers and proteins. A bile salt-dependent
micellarization has however been suggested for isoflavone agly-
cones (Walsh and others 2003). In the intestinal conditions, the
bioaccessibility and stability of polyphenols depends mainly on
pH. In near neutral conditions and in the presence of oxygen as
in most in vitro models, some phenolic compounds may be de-
graded through nonenzymatic oxidation (Bergmann and others
2009). Examination of specific classes revealed that flavan-3-ols
were poorly recovered following the digestion of a grape–orange–
apricot juice (Cilla and others 2009) but not in chokeberry juice
(Bermudez-Soto and others 2007). Pure (+)-catechin was recov-
ered at only 42% after incubation with pancreatin (Bermudez-
Soto and others 2007), while (–)-epicatechin and procyanidin B2
from homogenized apple were not recovered after the intestinal
step (Bouayed and others 2012). The high affinity of monomeric
and oligomeric flavanols for proteins and dietary fibers may also
lead to their loss during the solid removal step by centrifuga-
tion (Le Bourvellec and Renard 2011). For green tea flavanols,
the stability order was epicatechin > epicatechin gallate > epi-
gallocatechin = epigallocatechin gallate, which may reflect the
higher oxidizability of the 1,2,3-trihydroxyphenyl moiety com-
pared to the 1,2-dihydroxyphenyl one (Green and others 2007).
The recovery of caffeoylquinic acids appears to be more affected
by the intestinal step than by the gastric step as observed for ap-
ple, a grape–orange–apricot beverage, and red wine (Cilla and
others 2009; Gumienna and others 2011; Bouayed and others
2012). Chlorogenic acid (5-caffeoylquinic acid) may autooxidize,
although regio-isomerization is a major pathway as described
for p-coumaroyl- and caffeoylquinic acids by Kahle and others
(2011). Anthocyanins appear to be the most sensitive class and
may largely disappear in the intestinal step (McDougall and others
2005a, 2005b, 2007; Bermudez-Soto and others 2007; Tagliazuc-
chi and others 2010, 2012). The quantification of anthocyanins is
complicated by a pH-dependent equilibrium of the red flavylium
cation to several related structures at pH above 2. The hydration
of the flavylium cation produces a colorless hemiketal which is
in equilibrium with colorless (E)- and (Z)-chalcone forms. In the
near-neutral conditions of intestinal digestion, a 1st deprotonation
of the flavylium cation provides neutral quinonoidal bases (pKa 
4), which can further be deprotonated to ionic quinonoidal bases
(pKa  6), both bases displaying blue and violet hues (Brouillard
and others 1991; Clifford 2000). Thus, the detection of antho-
cyanins in simulated GI conditions can be challenging as it is
influenced by pH and copigment molecules. For example, Perez-
Vicente and others (2012) evaluated the recovery of pomegranate
anthocyanins to be 18% when measured at the pH of the intestinal
digesta and 70% following acidification of the digesta at pH 2.
Analysis of anthocyanins at pH lower than 2 should be favored
as it is more convenient to evaluate the flavylium cation form by
high-performance liquid chromatography (HPLC) or colorimet-
ric tests.
When exposed to acids or bases, ester bonds in ellagitannins
and in caffeoylquinic acids are hydrolyzed and the ellagitannins
yield hexahydroxydiphenic acid which is spontaneously rearranged
into the water-insoluble ellagic acid (Clifford and Scalbert 2000).
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Table 3–Concentrations of intestinal enzymes and bile salts in humans studies and in vitro experiments.
A—In vitro studies
Pancreatinb Minimum
Type Bile saltsa concentration, pancreatin activity Digestion Study/
of study (mmol/L) approximately (mg/L) (U/mL)b pH time (min) reference
Bioaccessibility of
iron
Approximately
4(2 g/L)
300 2.4 7.5 150 (Miller and others 1981)
Bioaccessibility of
carotenoids
Approximately
8.6(4.3 g/L)
720 5.8 7 to 7.5 120 (Biehler and others 2011b)
Bioaccessibility of
carotenoids
12(6 g/L) 2500 20 7.5 120 (Yonekura and Nagao 2009)
Bioaccessibility of
carotenoids
4.4(2.1 g/L) 390 3.1 7.5 120 (Garrett and others 1999)
Bioaccessibility of
carotenoids
7.5(3.75 g/L) 600 4.8 7.5 30 (Hedre´n and others 2002)
Bioaccessibility of
carotenoids
2.8(1.44 g/L) 240 2.0 6.0 30 (Dhuique-Mayer and others
2007)
Bioaccessibility of
carotenoids
3.0(1.5 g/L) 250 2.0 Approximately 7 120 (Liu and others 2004)
Bioaccessibility of
polyphenols
3.0(1.5 g/L) 250 2.0 5 to 7.5 120 (Gil-Izquierdo and others
2002)
Bioaccessibility of
polyphenols
4.3(2.2 g/L) 360 2.9 6.5→7.0 to 7.5 165 (Bouayed and others 2011)
Bioaccessibility of
polyphenols
44(22 g/L) 3600 29 6.5 120 (Cilla and others 2011)
Bioaccessibility of
polyphenols
10(5 g/L) 800 6.4 7.5 120 (Tagliazucchi and others
2012)
Bioavailability of
polyphenols
10(5 g/L) 800 6.4 Nd 120 (McDougall and others
2005a, 2005b)
B—Human studies (in vivo)
Fluid investigated Bile salts Lipase
and type of study pH (mmol/L) activity (U/mL) Study/ reference
Duodenal fluids; jejunal fluids 7.0 ± 0.4 0.6 to 5.5 (fasted) Nd (Perez de la Cruz Moreno and
others 2006)
6.8 ± 0.4
Duodenal fluids Nd 3.8 to 11.8 (fed) Nd (Van Deest and others 1968)
(2 to 6 g/L)
Duodenal fluids (standard
meal)
Nd 5 to 10 (fed) Nd (Tabaqchali and others 1968)
Duodenal fluids (standard
meal)
5.5 to 8.0, mean 6.5 20 (fed) 15 to 120 (fed) (mean 50)c (Borgstrom and others 1957)
(2 to 18 g/L)
Review article Nd 4 to 20 (fasted) Nd (Garidel and others 2007)
Orlistat and enzyme activity 6 to 6.5 Nd 1000 (fed)d (Sternby and others 2002)
(0.6 g/L)
Pancreatic enzyme
examinations.
Nd Nd 70 to 1000, mean 300c (Braganza and others1978)
Duodenal fluids (after regular
diet)
Nd Nd 10 (fasted), 130 (fed)c (Dukehart and others 1989)
Review lipolysis Nd 3 to 7 (fasted) 150 to 300c (Patton and Carey 1981;
Zangenberg and others
2001a, 2001b)
5 to 15 (fed)
Fasting18 individuals 5 to 9, mean 7 2.7 ± 1.3 Units not comparable to other
tests
(Ulleberg and others 2011)
(fasted)
Duodenal fluids 6.2 (fasted) 2.6 (fasted) Nd (Kalantzi and others 2006)
6 to 14 individuals 5.2 to 6.6 (fed) 11.2 (fed 30 min)
(median) 5.2 (fed 180 min)
Duodenal fluids 6.0 to 7.0 5.9 ± 1.8 (fasted) 600 (fasted)d (Armand and others 1996b)
Test meal 6.7 to 13.4 (fed) 1200 to 1400 (fed)d
Duodenal juices:
Meal—Review
Nd Nd 80 to 7000d (Armand 2007)
Small intestinal transit time
(min)
90 (Kim 1968)
GI passage times (min) 197 (Degen and Phillips 1996)
GI passage times (min) 199 (Yu and others 1996)
aValues calculated from weight assuming a molecular weight of 500 g/mol and 100% purity.
bPancreatin typically used: 4× U.S. Pharmacopoeia specifications (i.e. 4 times: 2 USP units lipase; and both 25 USP units protease and amylase). Definition lipase: 1 unit liberates at least 1 μmol acid from olive
oil/triolein per minute at 37 °C and pH 9 (http://www.pharmacopeia.cn/v29240/usp29nf24s0_m60320.html). Definition protease: hydrolyses casein at an initial rate such that there is liberated per min
an amount of peptides not precipitated by trichloroacetic acid that gives the same absorption at 280 nm as 15 nmol of tyrosine (http://www.pharmacopeia.cn/v29240/usp29nf24s0_m60320.html).
Definition amylase: decomposes starch at an initial rate such that 0.16 umol of glycosic linkage is hydrolyzed per min at pH 6.8 (and conditions further described for the amylase assay,
http://www.pharmacopeia.cn/v29240/usp29nf24s0_m60320.htm).
cSame as USP units.
dTributyrin units: 1 TBU (lipase unit) is the amount of enzyme which releases 1 mmol titratable butyric acid per min at 40 °C, pH 7.5. Yields comparable results to triolein units when expressed at same unit of
molarity (McCoy and others 2002).
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Daniel and others (1991) showed that ellagic acid could be re-
leased from raspberry ellagitannins at pH 7 and optimally at
pH 8. Furthermore, Gil-Izquierdo and others (2002) observed a
5- to 10-fold increase in ellagic acid from strawberry ellagitannins
during incubation with pancreatic enzymes in mild alkaline con-
ditions (Gil-Izquierdo and others 2002). This may be the mecha-
nism behind the relative increases in smaller ellagitannin molecules
noted during in vitro digestion of raspberry and strawberry extracts
(McDougall and others 2007; Brown and others 2012). In the
mildly alkaline conditions of in vitro digestion, orange flavanones
rearrange to form less soluble chalcone forms which can precip-
itate (Gil-Izquierdo and others 2003). However, more than 90%
of orange flavanones and 80% of soy isoflavone glycosides were
recovered after the intestinal step, outlining their high stability
toward autoxidation (Gil-Izquierdo and others 2003; Walsh and
others 2003). The sensitivity to autoxidation is probably overesti-
mated in in vitro digestion models as oxygen levels are lower in the
GI tract. Last, it should be noted that proteolytic enzymes could
play a role in polyphenol bioaccessibility by releasing phenolic
compounds bound to dietary proteins as observed in the gastric
tract for pepsin. However, more data support a role for phenolic
compounds as inhibitors of intestinal enzymes such as trypsin and
lipase (He and others 2006; Gonc¸alves and others 2007).
Static models. Conditions used in in vitro static models sim-
ulate quite well the physiology of intestinal digestion with the
use of porcine pancreatin, biliary extract or bile salts, and a pH
ranging between 6.0 and 7.5 (Table 3). However, the time al-
lowed for this step is highly variable (0.5 to 2.5 h). A too short
digestion time may lead to trapping of carotenoids in triglyc-
erides, and thus underestimate carotenoid bioaccessibility (Sy and
others 2012a). Different carotenoids show differing micellariza-
tion. Xanthophylls (lutein and β-cryptoxanthin) showed higher
micellarization compared to α- and β-carotenes, while lycopene
was only slightly micellarized (Garrett and others 2000; Reboul
and others 2006; Thakkar and Failla 2008). There have also been
differences noted between (E)-carotenoids and their (Z)-isomers
(Chitchumroonchokchai and others 2004; Bengtsson and others
2010), with the latter commonly found in processed foods, also
tending to be better micellarized (Bohn 2008). It could also be
speculated that a prolonged time of small intestinal digestion will
favor the formation of more Z-isomers. However, the in vivo data
showed no significant isomerization either in the stomach or in
the duodenum for β-carotene and lycopene (Tyssandier and others
2003).
In many in vitro studies, the stability of phenolic compounds has
been assessed by determining total phenolic content such as by the
Folin-Ciocalteu method (Singleton and Rossi 1965), which does
not yield information on the recovery of specific phenolic classes
or molecules. The recovery of total phenol content after the in-
testinal phase (when compared to the gastric step) was not reduced
for homogenized prunes (81% of the initial content; Tagliazucchi
and others 2012), grape berries (62%; Tagliazucchi and others
2010), cherries (127%; Fazzari and others 2008), pomegranate
juice (100%; Perez-Vicente and others 2002), and red cabbage
extract (100%; McDougall and others 2007). However, a loss in
total phenolics during the intestinal step was observed for plums
(44%), peaches (37%), tomatoes (31%; Tagliazucchi and others
2012), chokeberry juice (73%; Bermudez-Soto and others 2007),
raspberry extract (86%; McDougall and others 2005b), and red
wine (47% and 58%; McDougall and others 2005b), many of
which contain labile anthocyanins. In conclusion, the analysis of
specific phenolic compounds, and their possible degradation prod-
ucts, should be addressed to avoid conflicting results. Additionally,
findings on the recovery of different classes in 1 fruit/vegetable
cannot be readily extended to other sources as stability in vitro is
influenced by interactions with the other phenolic compounds in
the mixture and with other components such as vitamin C (for
example, through sacrificial oxidation).
Dynamic models. To simulate the in vivo conditions of the small
intestine, dynamic models can be used to reproduce pH changes
and secretion of pancreatic juice and bile. In the TIM model,
the intestinal transit time and pH conditions in the human diges-
tive tract are simulated through preprogrammed pH and delivery
curves (Minekus and others 1995). Porcine pancreatin, bile salts,
electrolytes, and NaHCO3 are secreted by computer-controlled
pumps. The model does not mimic brush border secretions. The
pH is usually increased between the duodenal, jejunal, and ileal
compartments, for example, from 6.4 to 7.2 for the digestion of a
tomato-containingWestern diet (Blanquet-Diot and others 2009).
The GI transit time may greatly influence the bioaccessibility of
phytochemicals by affecting the release from the food matrix. Ad-
ditionally, the solubility and stability of different compounds may
be affected by the time they are exposed to the conditions in the
intestinal tract. Apart from the integration of key parameters of
digestion such as transit time, peristaltic mixing, and transport,
the ability to remove digested material by passive absorption of
water and digested molecules through a dialysis system is also an
important feature of in vitro models. In particular, removal of di-
gested molecules may prevent product inhibition of the pancreatic
enzymes (Minekus and others 1995).
The TIM-1 and Tiny-TIM systems have been used to study the
digestive stability of carotenoids from tomato, and phenolic acids
present in bread, respectively (Blanquet-Diot and others 2009;
Hemery and others 2010). The TIM-1 system can be equipped
with semipermeable hollow fiber membrane filters (with a molec-
ular weight cutoff ranging between 3 and 5 kDa to 5 and 8 kDa,
depending on filter type) connected to the jejunal and ileal com-
partments in order to remove degraded compounds and to simulate
absorption of water-soluble nutrients. For the estimation of the
bioaccessibility of lipophilic carotenoids, the incorporation into
micelles is crucial and for this purpose the TIM system must be
equipped with a specific membrane that separates the micellar
phase from the fat phase (Minekus and others 2005). The pres-
ence of fat and bile salts is one of the factors that condition the
formation of micelles which should be less than 10 nm in diame-
ter. Moreover, protocols of digestion must be optimized to ensure
triglyceride hydrolysis and micellarization by bile salts.
General considerations. The contribution of the intestinal step
to the bioaccessibility of phenolic compounds is clearly influenced
by several parameters. First, the action of intestinal enzymes on
the residual matrix could increase the phenolic content. Next,
phenolic compounds are chemically reactive in near-neutral con-
ditions and their degradation or isomerization may be catalyzed
by the presence of oxygen and/or transition-metal ions. Addi-
tionally, specific absorption by the small intestine can occur by
passive diffusion or active transport, as demonstrated for aglycones
and their glucosylated forms. The latter forms can be actively
transported by the sodium–glucose-linked transporter 1 (SGLT1)
found in the enterocytes. Extracellular hydrolysis can be promoted
by lactase phlorizin hydrolase in the brush border and be followed
by diffusion of the resulting aglycone into the enterocyte (Day
and others 2000). A transcellular transport involving multidrug
resistance protein and P-glycoprotein transporters appears to be
favored for hydroxycinnamic acid and flavonol aglycones (Poquet
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and Clifford 2008; Barrington and others 2009). These 2 phe-
nomena cannot be readily modeled in vitro. Therefore, in vitro
digestion methods may overestimate the levels of these phenolic
components.
In summary, limiting oxygen levels; an inclusion of brush bor-
der enzymes or other α-glucosidase activities; a sufficient bile
salt concentration; and the presence of lipolytic, amylolytic, and
proteolytic enzymes for specific nutrient digestion are all of
importance for an optimal release of phytochemicals. While re-
maining triglycerides may trap lipid-soluble phytochemicals, in-
completely digested proteins and polysaccharides may bind to
water-soluble phytochemicals, making them unavailable in the
small intestine.
Large intestinal bioconversions
The colon contains a highly complex microbial ecosystem,
which is capable of fermenting food components not digested
in the upper GI tract. Some undigested food ingredients, includ-
ing certain polyphenols, can act as substrate for the indigenous
bacterial community (Possemiers and others 2011). In addition,
products from microbial bioconversion can affect the intesti-
nal ecosystem and the bioavailability of the parent compounds.
Carotenoids are typically not studied in colonic models, as they are
primarily absorbed in the small intestine, and colonic metabolites
have not been reported so far. Colonic bioconversion of phenolic
compounds is most well described for flavonoids, and phytoe-
strogens, lignans and isoflavonoids (Table 4). The complexity of
in vitro colonic models used to study the metabolism of pheno-
lic compounds is diverse, ranging from batch fecal incubations
using a strictly anaerobic and dense fecal microbiota suitable for
metabolic studies (Barry and others 1995; Gross and others 2010;
Aura and others 2012) to more complex continuous models in-
volving 1 or multiple connected, pH-controlled vessels to mimic
different parts of the human colon (Fogliano and others 2011) or
in vitro dynamic GI-colonic system models (Gao and others 2006;
Van Dorsten and others 2012), which are applicable also to study
effects of food components on the microbial population.
Characterization of phenolic metabolites using in vitro colonic
models is complementary to the metabolic bioconversion by
the small intestine or the liver (methylation, sulfation, and glu-
curonidation) of the native forms that are present in foods (Scalbert
and others 2002) and shows the diversity of structural transfor-
mations occurring in the colon prior to absorption (Aura 2008;
Selma and others 2009). Colonic metabolism of phenolic com-
pounds starts with the transient appearance of aglycones and the
subsequent formation of hydroxylated aromatic compounds and
phenolic acids (Rechner and others 2004; Aura 2008). Flavones,
flavanones, flavanols, proanthocyanidins, and phenolic acids share
hydroxyphenylpropionic acid metabolites (Rechner and others
2004; Aura 2008), whereas flavonols (quercetin, myricetin) and
ferulic acid dimers share hydroxylated phenylacetic acid metabo-
lites (Aura and others 2002; Braune and others 2009). Moreover,
flavanols also yield hydroxyphenylvaleric acids and corresponding
valerolactone derivatives (Aura and others 2008; Sanchez-Patan
and others 2012). Anthocyanins yield benzoic acids, hydroxy-
lated benzaldehydes, and acetaldehydes (Aura and others 2005;
Fleschhut and others 2006; Czank and others 2013). Complex
microbial metabolites, such as lactones formed from plant lignans
or ellagitannins (Heinonen and others 2001; Cerda and others
2004), are reabsorbed from the colon and are subject again to liver
metabolism and the conjugate derivatives are excreted via urine
(Adlercreutz and others 1995). Thus, plasma and urine excretions
reflect both the hepatic and colonic metabolism of polyphenols
(Table 4).
Limitations of in vitro colonic models include that they may not
fully represent the microbiota present in the colonic lumen and
mucosa and that the combined rates of catabolism and absorp-
tion that occur in vivo are not reproduced. However, the use of
colonic models provides information on the types of microbial
metabolites formed (Table 4) and helps to elucidate the pathways
involved. Static or batch models are of particular interest for a 1st
assessment of colonic metabolism of phenolic compounds, which
can be complicated by a high interindividual variability (Gross and
others 2010), or for comparison of different sources or doses of
compounds (Bolca and others 2009). The anaerobic batch colonic
model developed by Barry and others (1995), which uses pooled
human feces from several healthy donors, has been particularly
suitable when coupled with a metabolomics platform to investi-
gate the effects of structure and dose of fruit proanthocyanidin
fractions on the efficiency of microbial metabolism and structure
of flavanol monomers (Aura and others 2008; Aura and others
2012).
Dynamic, multicompartment colonic models are useful for
long-term experiments needed to evaluate the spatial and tem-
poral adaptation of the colonic microbiota to dietary phenolic
compounds and the microbial metabolism of these phytochem-
icals. These models are designed to and should harbor a repro-
ducible microbial community that should be stable upon inoc-
ulation, colon region-specific, and relevant to in vivo conditions
(Macfarlane and others 1998; Van den Abbeele and others 2010).
Dynamic colonic models have shown that microbial metabolism
of black tea and red wine (Van Dorsten and others 2012) and co-
coa (Fogliano and others 2011) is dependent on colon location. In
addition, dynamic models may be used to enrich the colonic mi-
crobiota with polyphenol-converting species such as Eubacterium
limosum to increase the production of 8-prenylnaringenin from
hop extracts (Possemiers and others 2008). New tools to improve
modeling the physiological colonic conditions have been inte-
grated into dynamic systems, such as the incorporation of a mu-
cosal environment (Macfarlane and others 2005; Van den Abbeele
and others 2012) and a mucus layer combined with epithelial cells
(Marzorati and others 2011). These models can differentiate be-
tween the luminal microbiota with a large metabolic degradation
capacity and the mucosa-associated microbiota able to closely in-
teract with the host.
An important element to be considered for designing colonic
model experiments is the use of 1 or multiple fecal donors in
terms of diversity of the microbiota population, as high- and
low-polyphenol metabolizing phenotypes can skew the extent
of metabolism of certain compounds (Selma and others 2009;
Bolca and others 2012). Meanwhile, comparison of human gut
metagenomes has suggested the classification of individuals into 3
distinct enterotypes (Arumugam and others 2011). The mainte-
nance of anaerobic conditions during stool processing and inocula-
tion to the models is crucial for microbial and enzymatic activities.
Another important matter to be considered is the pH adjustment
needed to avoid suppression of particularly minor conversion ac-
tivities (for example, slow enterolactone formation (Aura 2008)).
In summary, in vitro colonic models are the preferred choice to
study mechanisms of polyphenol microbial metabolism as well as
the polyphenol-induced modulation of gut microbiota. However,
the ability of colonic models to simulate the in vivo conditions is
limited by the lack of studies involving the formation of micro-
bial biofilms adhering to the colonic epithelium. The simulation
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of intestinal absorption to remove end products of microbial
metabolism is also relevant to prevent inhibition of the colonic
microbiota during in vitro studies.
Determination of bioaccessible fraction and further cou-
pling techniques following digestion and/or colonic
fermentation
In vitro digestion model systems either simulate disintegra-
tion processes only (for bioaccessibility) or both digestion and
absorption processes (for bioavailability estimates). According to
the desired end points of the studies, there are considerable dif-
ferences in the type of experimental parameters measured after
digestion. These may include chemical changes (such as hydrolysis
of macronutrients), gastric solubilization of drugs, nutrient avail-
ability, release of encapsulated components, studying competitive
processes, and structural changes (such as breakdown of specific
structures), aggregation, droplet coalescence, or droplet disruption
(Chen and others 2011). Thus, samples obtained by in vitro diges-
tion, either following small intestinal digestion or following further
colonic fermentation in vitro, have been used in a variety of ways.
In addition, the obtained fractions have been coupled to further
investigation procedures, allowing, for example, the estimation of
uptake into or transport through the intestinal epithelium.
Estimation of bioaccessibility. The estimation of the bioacces-
sibility of nonpolar food constituents such as carotenoids has been
made both by measuring the transfer of carotenoids from the food
matrix to the aqueous layer obtained after in vitro digestion and
centrifugation (Hedre´n and others 2002; Bengtsson and others
2009) or by filtering the aqueous fraction through a 0.22-μm
membrane to obtain mixed micelles (Reboul and others 2006;
Huo and others 2007), or both. Since the micellarized carotenoids
are considered to be the form in which these compounds will ul-
timately be absorbed by the intestinal cells, it has been suggested
that assessment of carotenoid bioaccessibility must include the
isolation, extraction, and measurement of carotenoids in micelles
(Etcheverry and others 2012). Reboul and others (2006) showed a
high correlation (r = 0.90) of the in vitro bioaccessibility of α- and
γ -tocopherol, β-carotene, and lycopene with the in vivo values
measured in the micellar phase from human duodenum during
digestion of a carotenoid-rich meal. Their findings suggest that
estimation of carotenoid micellarization in vitro can be indicative
of the amount available for uptake in the GI tract in vivo.
For polyphenols, Bouayed and others (2011, 2012) studied
bioaccessibility following simulated gastric and intestinal in vitro
digestion of fresh apple. They used a cellulose semipermeable
membrane, chosen as a simplified mechanical model for the ep-
ithelial barrier to identify dialyzable polyphenols after intestinal
digestion. They suggested that dialyzable polyphenols in the in-
testinal phase could potentially be taken up by the enterocytes
and proposed it may be a practical step prior to coupling to cel-
lular methods due to increased purity of the dialysate, preventing
negative impacts on cell viability. Similar studies were performed
by other researchers (Liang and others 2012; Tavares and others
2012; Rodriguez-Roque and others 2013). At the same time, it
is difficult to study the in vivo changes and digestive stability of
different food constituents during their passage through the diges-
tive tract, although some approaches, such as studying ileostomists,
have allowed some comparisons to in vitro small intestinal digestion
(Walsh and others 2007; Erk and others 2012).
Bioaccessibility following colonic fermentation. In vitro diges-
tion procedures have also been employed to produce berry sam-
ples that are characteristic of components that survive diges-
tion, and therefore are more physiologically relevant, for stud-
ies on bioactivities concerning colon cancer models (Brown and
others 2012).
Due to the limited sampling possibilities (and intra- and in-
terindividual variations), the function and the composition of ileal
microbiota is hard to study in vivo. The effect of small intesti-
nal microbiota on the enzymatic hydrolysis of phenol glycosides
was studied in an ex vivo ileostomy model (Knaup and others
2007). Ileostomy effluents from 3 healthy subjects were used for
incubation with synthetic quercetin and p-nitrophenol glycosides.
The conclusion was that the hydrolysis of phenol glycosides is
influenced both by the structural components of the phenols and
the microbiota in the small intestine. Schantz and others (2010)
have also reported evidence of degradation of polyphenols in the
small intestine, using an ex vivo ileostomy model to study the mi-
crobial metabolism and chemical stability of green tea cathechins
and gallic acid. According to studies in ileostomy patients, the
ileal microbiota is restored 6 mo after surgery (Mortensen and
Clausen 1996), which may resemble the reflux situation occur-
ring in subjects with a healthy colon, or even take the role of
colon fermentation to some extent in ileostomy patients.
Phenolic microbial metabolites are relevant in terms of hu-
man health because they appear in plasma and are excreted in
urine (Aura 2008). Pharmacokinetic studies show that microbial
metabolite concentrations are elevated for up to 24 to 48 h in the
bloodstream after a single dose of their precursors before return-
ing to baseline values (Sawai and others 1987; Gross and others
1996; Kuijsten and others 2005). Enterolactone, enterodiol, and
urolithins are excreted via urine as hepatic conjugates (Heinonen
and others 2001; Cerda and others 2004). Microbial phenolic acid
metabolites appear in urine mainly in a free form in contrast to
beverage-derived phenolic acids, which are excreted mainly as sul-
fates and glucuronides (Sawai and others 1987; Stalmach and others
2009). In a recent work, Ludwig and others (2013) have shown
that after ingestion of coffee, the main colon-derived metabolites
found in plasma and/or in urine were dihydrocaffeic acid, dihy-
droferulic acid, and their sulfated and glucuronidated metabolites.
The metabolites described above and their hepatic conjugates are
found in plasma and urine and circulate through the body, and
may therefore exhibit both local and systemic effects. Phenolic
metabolite levels in plasma range from low to high nano mo-
lar concentrations (Sawai and others 1987; Kilkkinen and others
2001; Kern and others 2003; Johnsen and others 2004; Kuijsten
and others 2006), whereas urinary levels are at the micromolar
range. In peripheral tissues, the concentrations can be anticipated
to be even lower.
A good example of studies encompassing in vitro digestion
models and colon conversion and pharmacokinetic studies in
human volunteers was performed by Mateo Anson and others
(2009, 2011). The group showed that bioprocessing of wheat
bran with enzymes (xylanase, cellulose, β-glucanase, and feruloyl
esterase) and yeast enhanced the bioaccessibility of ferulic acid,
para-coumaric acid, and sinapic acid from white wheat bread ma-
trix in the in vitro GI models TIM-1 and TIM-2 by 5-fold. Since
the release of para-coumaric acid and sinapic acid occurred mainly
in the TIM-1 model simulating the upper intestine, the microbial
conversion products (3-(3’-hydroxyphenyl) propionic acid and 3-
phenylpropionic acid) from the TIM-2 colon model were shown
to be related to matrix bound ferulic acid (Mateo Anson and others
2009). In a subsequent pharmacokinetic in vivo study, volunteers
consumed 300 g white wheat bread samples fortified with either
native or bioprocessed wheat bran, and then phenolic acids and
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Table5–Summarized parameters for simulateddigestion under static conditions, basedon common in vitro values applied, feasibility, and their similarity
to in vivo conditions.
Phase of digestion Common in vitro valuesa Common in vivo valuesa Tentatively suggestedb
Oral phase
α-Amylase (U/mL)c 110 26 25 to 200
Time (min) 10 0.5 to 5 1 to 5
pH 6.9 7.1 ± 0.1 7.0 ± 0.2
Gastric phase
Pepsin (U/mL) d,f 1400 to 4300 1400 to 3700; 2000 to 10000
Time (min) 60 60 to 72;140 to 210e 60; 120e
pH 2.0 2 (fasted); 3.5 (120 min [fed]g) 3.5 ± 0.5
Small intestine
Lipaseh 4.0(0.5g/L) 70 to 1000 (fed);10 (fasted) 20 to 200
Bile salts (mmol/L) 7.5(3.8 g/L) 5 (fasted)10 (fed)g 10
Time (min) 120 200 120 to 200
pH 7 to 7.5 6.8 ± 0.4 7 ± 0.2
Large intestine
Time (h) 42 (24 to 72) 35 ± 2.1 35 to 45
pH 6.6 (5.5 to 7.2, start)6.6 (end) 6.2 (5.7 to 6.7) 6.2 to 6.6
aMedian value taken from Table 1 to 4.
bTaking into account human trials (Table 1 to 4) and herein reported physiological values.
c“Sigma units”(see Table 1). For conversion into IFCC units ×0.0073 (that is, 140 units = 1.02 IFCC units).
d“Sigma units:” Pepsin typically used: 800 to 2500 units/mg such as by Sigma-Aldrich. One unit: One unit will produce a change in absorbance of 0.001 at 280 nm at 37 °C, in 1 min, at pH 2.0, with hemoglobin
as substrate. See footnotes of Table 2 for conversion factors.
eLiquid and solid meals, respectively.
fGastric lipase not required for water soluble compounds, however for lipophilic compounds such as carotenoids a concentration of 40 to 80U/mL is recommended (Armand 1999, 2007). Gastric lipase (tributyrin
units): 10 to 65 (mean 40, Armand 1999); 60 to 80 (Armand 2007). One TBU (lipase unit) is the amount of enzyme (g) which releases 1μmol titratable butyric acid perminute under the given standard conditions.
gPostprandial.
hOne unit liberates at least 1 μmol of acid from olive oil/triolein per minute at 37 °C and pH 9. Comparable to tributyrin units when expressed at same molarity.
their metabolites were followed for 24 h. The release and conver-
sion of microbial metabolites were enhanced by bioprocessing of
bran by 2- to 3-fold and their time course profiles in plasma were
altered by bioprocessing of bran (Mateo Anson and others 2011).
Coupling digesta to uptake and transport models of the in-
testinal epithelium. More recently, human enterocyte cell cul-
ture models (such as Caco-2 cells) were coupled with simu-
lated GI models. Small intestinal digestive processes or follow-
ing further colonic fermentation have been widely used as a
predictive tool for the absorption of bioactive components from
foods (Chitchumroonchokchai and Failla 2006; Failla and others
2008a; Biehler and others 2010). Caco-2 is a cell line which orig-
inated from a human colon carcinoma, exhibiting some morpho-
logical and functional characteristics similar to those of differenti-
ated epithelial cells of the intestinal mucosa (Sambruy and others
2001). The in vitro digestion/Caco-2 cell culture model developed
by Glahn and others (1998) has been validated and offers a rapid,
low-cost method for screening foods and food combinations for
iron uptake before more definitive human trials (Hur and others
2011). Caco-2 cells have also been applied to a number of up-
take and transport studies for both hydrophilic constituents (such
as polyphenols) and lipophilic compounds (such as carotenoids).
The behavior of carotenoids from the in vitro digestion/Caco-
2 cell culture model has been well correlated, qualitatively and
quantitatively, with human data (Garrett and others 1999, 2000;
Mahler and others 2009). While the majority of studies have fo-
cused on simple uptake employing a biphasic model with the
apical membrane and the cell layer, transport models including
also an additional basolateral compartment are also available to al-
low the study of fluxes and, therefore, kinetic parameters through
the cell layer (Reboul and others 2006; Biehler and others 2010;
Manzano andWilliamson 2010). However, the latter requires tran-
swell inserts, which are more costly, and the concentrations to be
determined are usually lower and may require more sophisticated
analytical techniques for detection, such as mass spectrometry, and
it may not be feasible to study minor food constituents. More
recently, the Caco-2 cell model has been extended by adding a
layer of mucus-producing cells (such as HT-29 MTX cells) on top
of the Caco-2 cells. However, only preliminary data are available
on how this system performs compared to Caco-2 cells alone, al-
though this may represent a more realistic approach, which may
further hamper uptake of more lipophilic constituents due to the
additional mechanical barrier (Nollevaux and others 2006). Also,
Ussing chambers have been used to obtain a better understanding
of the transepithelial transport processes on a molecular basis. This
is a model that simulates the mucosa and its luminal/apical side
(Bergmann and others 2009; Clarke 2009). For example, Deusser
and others (2013) have used the Ussing chamber to evaluate apple
polyphenol transport and their effect on mucosal integrity.
Conclusions and Summary
Many considerations have to be taken into account when de-
termining bioaccessibility of phytochemicals by means of in vitro
digestion models. Two important criteria are whether the focus of
research is on hypothesis building and a large number of samples is
to be analyzed, which favor static models, or if closely simulating
physiological conditions is the primary aim, which favors the use
of dynamic models. An additional criterion is the lipophilicity of
the phytochemicals of interest. For hydrophilic compounds such
as for polyphenols, often associated with fiber or complex car-
bohydrates, amylase digestion and perhaps particle size appear to
play predominant roles. Whereas, for lipophilic compounds, (such
as carotenoids) emulsifying agents (presence of dietary fats, bile
salts, and sufficient lipolytic activity), appear crucial, thus their use
during digestion should be well considered and standardized. This
also includes adjusting pH values and allowing sufficient digestion
times for optimal enzyme function comparable to the in vivo sit-
uation. The suggested conditions for static digestion models are
outlined in Table 5. These parameters represent a consensus from
commonly employed conditions for simulated static in vitro diges-
tion (Table 1 to 4), but also take into account practical aspects
(such as availability of enzymes) but, most importantly, are also
similar to the in vivo situation. In addition, lipophilic phytochem-
icals require separation of the micellar fraction prior to further
investigations, via ultracentrifugation (static model), filtration, or
employing a membrane (dynamic model). Coupling the cell-based
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uptake model with colonic digestion models is a comparatively
novel but important completion of modeling digestion. This may
especially be suitable for compounds such as polyphenols, which
are metabolized and taken up from the colon.
Untilnow, the lack of consensus values for the digestion param-
eters has hampered possibilities to compare results across differ-
ent studies. Though the suggested conditions are based on rel-
evant in vivo data, further studies are required to validate their
use and limitations in phytochemicals digestion. Mindful of their
limitations, much insightful information has been gained from
applying in vitro digestion models to phytochemical research. The
recent improvements in our understanding and the advances in the
technology warrant continuous research in the important area of
bioavailability.
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